Key Highlights

  • Rentokil Initial plc (LSE:RTO) fell 1.81%, or 5.50p, to close at 298.50p on 29 September 2026, below the 300p mark and at a new 52-week low.
  • The shares have now fallen by around 40% from their 52-week high of about 507p.
  • Last week the group agreed to sell SOLitude Lake Management and Vertex Aquatic Solutions to Bain Capital for $230 million, with net cash proceeds of about $180 million.
  • First-half Revenue rose 4.5% to $3.589 billion but came in below market expectations.
  • Investors are looking to the third-quarter trading update for evidence of a North American recovery.

Rentokil Slides Below 300p

Rentokil Initial plc (LSE:RTO) extended its losing streak on Tuesday, falling 1.81% to 298.50p and ranking among the five biggest fallers in the FTSE 100. The move took the pest control and hygiene group to a fresh 52-week low, breaking below the 300p level that many traders had viewed as a key support zone.

The decline continued a difficult run. The stock had already dropped nearly 4% on 24 September and fell a further 1.5% on Monday, erasing the brief bounce that followed news of its latest disposal. The shares have lost roughly 40% from their 52-week high and have been among the weakest large caps in London this year.

Asset Sale Fails to Lift Sentiment

On 22 September, Rentokil agreed to sell its US water-quality businesses, SOLitude Lake Management and Vertex Aquatic Solutions, to Bain Capital for total consideration of $230 million on a cash-free, debt-free basis. The company expects net cash proceeds after tax of about $180 million and said the transaction further reduces Leverage within its target range.

SOLitude generated $112 million of revenue and $16 million of adjusted operating profit in fiscal 2025, meaning it was a relatively small, non-core part of the group. The shares initially rose more than 2% on the news, but the gain proved short-lived as investors refocused on the core pest control business, particularly in North America.

Why Rentokil Stock Is in Focus

Rentokil is the world's largest pest control company, with a major presence in the United States following its $6.7 billion Acquisition of Terminix. That deal was meant to give the group scale in the world's biggest pest control market, but integration has proved harder than expected, and organic growth in North America has repeatedly disappointed.

First-half 2026 revenue rose 4.5% to $3.589 billion, while operating profit rose 6.6% to $556 million. However, revenue fell short of consensus of about $3.661 billion, a gap of roughly $72 million. Cash generation was a relative bright spot, and the company has also announced organisational changes and Leadership appointments aimed at sharpening execution.

Credit rating agency Fitch affirmed Rentokil's BBB rating with a stable outlook in mid-September, citing its established market position and committed financial policy. That offers some comfort on the balance sheet, even as Equity investors remain cautious.

Key Reasons Behind the 1.81% Decline

The first reason is persistent concern over North American growth. Investors want clear evidence that the Terminix integration is delivering improved organic revenue growth and Margin expansion, and the first-half revenue miss reinforced doubts.

The second reason is technical selling. Breaking below the 300p level and previous lows can trigger stop-loss orders and momentum-driven selling, amplifying the move.

The third reason is the broader market backdrop. Global Bond yields surged on Tuesday, with the US 30-year Treasury Yield reaching its highest level since 2002. Higher yields hurt stocks that are valued on long-term recovery potential, and they increase the cost of servicing Debt for leveraged groups.

Analyst Views Remain Split

Despite the share price weakness, several Brokers see value. Investec upgraded Rentokil to buy on 23 September, and the average analyst rating remains moderate buy, with a consensus price target of around 455p, well above current levels. That gap reflects the view among bulls that the market is overly pessimistic about the recovery potential in North America.

Bears, however, argue that the company needs to show consistent delivery before the shares can re-rate, and that repeated guidance disappointments have eroded investor confidence.

What Investors Should Watch Next

The next dated operating milestone is the third-quarter trading update, where investors will focus on North American organic growth, pricing, customer retention and cost savings from the Terminix integration. Any sign of stabilisation could trigger a sharp relief rally given the depressed valuation.

Investors will also track further portfolio actions, use of disposal proceeds and progress on reducing leverage. Macro factors, including US consumer confidence and borrowing costs, will remain important given the group's heavy exposure to the American market.